Satoshi Sato

Hakodate Central General Hospital

Papers

1

Total Citations

5

H-Index

1

About

Dr. Satoshi Sato is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for muscle-invasive bladder cancer (MIBC), particularly through the comparative analysis of robot-assisted versus open surgical techniques. His major contribution lies in providing real-world, multicenter evidence on the oncologic safety of robot-assisted radical cystectomy (RARC). In his most cited work, a 2025 multicenter retrospective study involving 429 patients, Dr. Sato critically examined whether RARC increases the risk of peritoneal carcinomatosis compared to open surgery, directly addressing a key clinical concern in the field. This study, which has garnered early attention with 5 citations, helps guide surgical decision-making for patients with MIBC. By leveraging large-scale, collaborative data, his research offers valuable insights into the prognostic implications of minimally invasive approaches, balancing oncologic efficacy with surgical innovation. Dr. Sato’s work is instrumental for surgeons and researchers seeking evidence-based comparisons to improve long-term patient outcomes in bladder cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Effects of Robot‐Assisted Radical Cystectomy on Peritoneal Carcinomatosis and Prognosis in Patients With Muscle‐Invasive Bladder Cancer: A Multicenter Retrospective Study
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Hakodate Central General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago